Verastem reported $-22786000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
AstraZeneca AZN:LN 1954M 415M
Curis CRIS:US $ -11.05M 0.21M
Cytokinetics CYTK:US $ -76.09M 14.53M
Epizyme EPZM:US $ -65.83M 1.47M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Immunogen IMGN:US $ -37.34M 6.6M
Laboratory Of America LH:US $ 842.8M 38.1M
Novartis NOVN:VX SF 4544M 120M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Verastem VSTM:US $ -22.79M 5.88M